-
The kl-A289 injection, an innovative drug in Collum Pharmaceuticals, was approved clinically
Time of Update: 2020-08-17
KL-A289 injection is a new generation of tumor immunocheckpoint inhibitors jointly developed by Colleen Pharmaceuticals and Anyuan Pharmaceuticals with independent intellectual property rights, the mechanism of action is relatively clear, which can lift the inhibition of anti-tumor T cells, enhance the body's immune response to tumors, and is intended to be used in the treatment of advanced solid tumors.
-
Delisted "old drug" gets new FDA approval for breakthrough therapy to treat rare childhood epilepsy
Time of Update: 2020-07-18
26, Zogenix announced that the U.S FDA has approved the listing of an oral solution for Fintepla (fenfluramine, fenfluramine) to treat seizures associated with Dravet syndrome in patients 2 years and
-
In the era of psoriasis treatment and biological agents, there are many giants, and Lilly new drug Tuozi is listed in China
Time of Update: 2019-11-11
In March 2016, taltz (Tuozi ®, iqzumab injection), a new generation anti-inflammatory drug of Lilly pharmaceutical, completed the largest phase III clinical trial based on the moderate to severe plaqu
-
The State Office issued a document emphasizing the supply and price stability of drugs in short supply and implementing the "1 + X" drug use mode
Time of Update: 2019-10-12
On October 11th, the general office of the State Council issued the opinions on Further Doing a good job in the work of ensuring supply and price stability of drugs in short supply The opinion points
-
April has been opened, and the new pharmaceutical industry trends have been sorted out
Time of Update: 2019-04-09
[China Pharmaceutical network industry trends] in the past three months, Chinese pharmaceutical enterprises have made new changes in personnel changes, financing and new drug research and development
-
Xinda biological anti-CD47 monoclonal antibody completed the first case of drug administration in phase I clinical study in the United States
Time of Update: 2019-03-20
March 19, 2019 / AP / -- Xinda biopharmaceutical Co., Ltd is a biopharmaceutical company dedicated to R & D, production and sales of innovative drugs for the treatment of major diseases such as tumors
-
Canada's green light for truvada to reduce HIV infection by 99
Time of Update: 2016-03-01
Source: Igua 2016-3-1 the Canadian government quietly lit a green light last week for a prescription drug that can prevent AIDS, agreeing to prescribe truvada for people in need, according to vice So
-
Calf blood drugs stop production for rectification? General Administration of food and drug: subject to the notice of Internet
Time of Update: 2016-01-19
Source: China economic network, January 19, 2016, June 2015, CFDA (State Food and Drug Administration) reported that Wuhan Hualong Pharmaceutical Co., Ltd was withdrawn GMP certificate and recalled re
-
EU approved the use of Avastin in platinum resistant recurrent ovarian cancer
Time of Update: 2014-08-07
Source: Wisdom News Agency (August 7, 2014) Roche announced on August 6, 2014 that the European Commission (EC) approved Avastin (common name: bevacizumab, bevacizumab), paclitaxel, topotecan or pegyl
-
Urumqi implements feed market access system
Time of Update: 2008-11-03
Introduction: from now on, all enterprises (stores) dealing in feed and feed additives must apply for the examination certificate of feed and feed additives This is the first feed market access system
